(Q43001701)

English

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution

scientific article published on 29 June 2010

In more languages
default for all languages
No label defined

No description defined

Statements

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution (English)
Michael Roughton
Panagiotis Kottaridis
Ruth Pettengell
Stephen Mackinnon

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit